Europe Syndromic Multiplex Diagnostic Market
시장 규모 (USD 10억)
연평균 성장률 :
% 
USD
1.17 Billion
USD
2.19 Billion
2024
2032
 예측 기간 |
2025 –2032 |
 시장 규모(기준 연도) |
USD 1.17 Billion |
 시장 규모(예측 연도) |
USD 2.19 Billion |
 연평균 성장률 |
% |
| 주요 시장 플레이어 |
|
유럽 증후군 멀티플렉스 진단 시장 세분화, 제품 유형별(액세서리 및 소모품, 기기, 소프트웨어 및 서비스), 감염 유형별(바이러스, 박테리아, 진균, 기생충 및 기타), 질병별(호흡기 감염, 위장염, 성병, 수막염 , 소아 감염, 면역 억제, 열대열, 간염, 안구 감염 및 기타 질병), 최종 사용자별(병원, 임상 검사실, 의원, 제약 및 생명공학 회사, 연구소 및 기타), 유통 채널별(직접 입찰, 소매 판매 및 기타) - 산업 동향 및 2032년까지의 전망
증후군성 멀티플렉스 진단 시장 분석
증후군 성 다중 진단 시장은 신속하고 정확한 진단에 대한 수요 증가와 감염병의 증가로 인해 상당한 성장을 경험하고 있습니다. 이러한 진단 플랫폼은 여러 병원균을 동시에 검출하여 효율성과 환자 치료 결과를 개선합니다. 주요 성장 동력으로는 분자 진단의 발전, 정부의 의료 인프라 투자, 그리고 개인 맞춤형 의료에 대한 인식 제고가 있습니다. 또한, 코로나19 팬데믹은 다중 진단 시스템 도입을 가속화했습니다. 주요 시장 참여자들은 제품 혁신에 집중하고 지역적 입지를 확대하며 시장 경쟁력을 강화하고 유럽 의료 분야의 전반적인 성장에 기여하고 있습니다.
증후군성 다중진단 시장 규모
유럽 증후군 멀티플렉스 진단 시장은 2024년 11억 7천만 달러에서 2032년 21억 9천만 달러로 성장할 것으로 예상되며, 2025년에서 2032년까지의 예측 기간 동안 8.2%의 CAGR로 성장할 것입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 적용 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 수입 수출 분석, 생산 능력 개요, 생산 소비 분석, 가격 추세 분석, 기후 변화 시나리오, 공급망 분석, 가치 사슬 분석, 원자재/소모품 개요, 공급업체 선택 기준, PESTLE 분석, Porter 분석 및 규제 프레임워크가 포함됩니다.
증후군성 다중진단 시장 동향
“증후군 다중진단 분야에서 현장진료 검사의 증가”
현장진료(Point-of-Care) 검사는 유럽 증후군 다중진단 시장에서 중요한 트렌드입니다. 신속한 현장 진단에 대한 수요 증가로 인해 휴대 가능하고 사용하기 쉬운 다중진단 장비의 도입이 증가하고 있습니다. 이러한 현장진료 솔루션은 여러 병원균을 더 빠르게 검출하고, 시기적절한 치료 결정을 내릴 수 있도록 하여 환자 치료 결과를 개선합니다. 이러한 추세는 특히 신속한 진단이 필수적인 응급 상황, 농촌 지역, 그리고 집단 감염 발생 시에 유용합니다. 소형 진단 기술의 발전으로 이러한 장비는 더욱 정확하고, 비용 효율적이며, 사용자 친화적으로 발전하여 유럽 전역의 의료 서비스에서 그 역할을 크게 확대하고 있습니다.
보고서 범위 및 증후군성 다중 진단 시장 세분화
|
속성 |
증후군성 다중 진단 핵심 시장 통찰력 |
|
다루는 세그먼트 |
|
|
포함 국가 |
독일, 영국, 프랑스, 이탈리아, 스페인, 러시아, 네덜란드, 스위스, 터키, 벨기에, 스웨덴, 폴란드, 덴마크, 노르웨이, 핀란드 및 기타 유럽 국가 |
|
주요 시장 참여자 |
F. Hoffmann-La Roche Ltd(스위스), DiaSorin SpA(이탈리아), BIOMÉRIEUX(프랑스), Thermo Fisher Scientific Inc.(미국), QIAGEN(네덜란드), BD Veritor(BD)(미국), Bio-Rad Laboratories, Inc.(미국), Danaher Corporation(미국), Seegene Inc.(한국), Hologic, Inc.(미국), Bosch Healthcare Solutions GmbH(독일), Abbott(미국), QuidelOrtho Corporation(미국), Biocartis(벨기에), PathoFinder(네덜란드) 등이 있습니다. |
|
시장 기회 |
|
|
부가가치 데이터 정보 세트 |
Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체 등 시장 시나리오에 대한 통찰력 외에도 심층적인 전문가 분석, 수입/수출 분석, 가격 분석, 생산 소비 분석, PESTLE 분석이 포함되어 있습니다. |
증후군성 다중진단 시장 정의
유럽 증후군 다중 진단 시장은 단일 검체에서 여러 병원체 또는 바이오마커를 동시에 검출하는 진단 검사 및 플랫폼을 의미하며, 이를 통해 감염성 질환, 암, 유전 질환 등 다양한 질병의 신속한 진단이 가능합니다. 이러한 진단을 통해 의료 서비스 제공자는 환자 증상의 원인을 신속하게 파악하여 치료 결과를 개선하고 의료비를 절감할 수 있습니다. 이 시장은 분자 진단 기술의 발전, 더 빠르고 정확한 검사에 대한 수요 증가, 그리고 개인 맞춤 의료에 대한 관심 증가에 힘입어 성장하고 있습니다.
증후군성 다중진단 시장 동향
운전자
- 감염병 유병률 증가
유럽 전역에서 감염병 부담이 빠르게 증가하고 있습니다. 바이러스, 진균, 박테리아, 기생충 등 다양한 병원성 미생물이 감염병과 관련이 있습니다. 감염병이 더욱 빈번하고 복잡해짐에 따라, 더욱 효율적이고 신속하며 포괄적인 진단 도구 의 필요성이 더욱 중요해지고 있습니다. 증후군 다중 진단은 단일 검사로 여러 병원체를 동시에 검출할 수 있도록 하는 해결책을 제공하며, 이는 신종 및 재유행 감염병 발생에 있어 점점 더 중요해지고 있습니다. 감염병 발생 사례 증가는 증후군 다중 진단율을 높이고 있으며, 감염병 유병률 증가는 시장 성장을 촉진하고 있습니다.
예를 들어,
2023년 12월, WHO는 WHO 유럽 지역 전역에서 계절성 호흡기 감염이 급증하고 있으며, 호흡기 세포융합바이러스(RSV), COVID-19, 인플루엔자, 마이코플라스마 폐렴균이 입원 증가를 주도하고 있다고 보고했습니다. 어린이, 노인, 기저 질환자는 더 큰 위험에 직면합니다. 예방 접종 및 위생 관리 강화를 포함한 예방 조치는 질병 완화 및 의료 시스템 부담 감소에 여전히 중요합니다.
유럽 전역에서 감염병 유병률이 증가함에 따라 첨단 진단 솔루션에 대한 수요가 증가하고 있습니다. 한 번의 검사로 여러 병원체를 검출할 수 있는 증후군 다중 진단법은 신속하고 정확한 질병 진단에 대한 증가하는 수요를 충족합니다. 이러한 추세는 시장 성장을 크게 촉진합니다.
- 분자 진단 기술의 채택 증가
분자 진단은 질병 진단, 치료 및 연구에 혁명을 일으키고 있는 빠르게 발전하고 변혁적인 분야입니다. 분자 진단은 감염성 질환을 종종 초기 단계에서 정확하게 식별할 수 있도록 합니다. 분자 진단에서 다중 PCR(중합효소 연쇄 반응) 패널 분석은 다양한 병원체의 유전 물질을 동시에 검출하여 감염성 질환을 진단하는 데 사용됩니다. 이러한 분석은 곰팡이, 기생충, 박테리아, 바이러스를 포함한 다양한 미생물을 여러 분류학적 수준에서 식별할 수 있습니다.
분자 진단 기술에 대한 의존도가 높아짐에 따라 병원균 검출은 더욱 포괄적이고 효율적이 되었습니다. 멀티플렉스 PCR과 첨단 시퀀싱 기술은 신속하고 정확한 질병 진단을 가능하게 하여 궁극적으로 환자 치료 결과를 개선하는 데 중요한 역할을 합니다. 정확하고 시기적절한 의료 솔루션에 대한 수요 증가는 시장 혁신을 주도하여 임상 의사 결정 개선과 더욱 효과적인 치료 전략으로 이어지고 있습니다.
예를 들어,
2024년 3월, Elsevier Inc.에서 발표한 논문에 따르면, 분자 진단 기술, 특히 PCR 기반 방법의 도입 증가는 감염성 질환 진단 방식에 큰 변화를 가져왔습니다. FDA 승인을 받은 다중 PCR 패널은 이제 높은 민감도와 빠른 결과로 호흡기 감염의 원인균을 검출할 수 있습니다. 이 패널은 시기적절하고 정확한 진단을 가능하게 할 뿐만 아니라 항균제 치료 결정에 도움을 주어 궁극적으로 임상 결과를 개선하고 환자 치료를 최적화합니다.
분자 진단 및 증후군 멀티플렉스 기법의 사용이 증가함에 따라 다양한 감염에 대한 빠르고 정확한 결과를 제공함으로써 의료 환경이 혁신되고 있습니다. 이러한 혁신은 진단 과정을 간소화하고 비용을 절감하며 치료 정확도를 높여, 전 세계적으로 복잡한 질병을 해결하고 환자 치료를 개선하는 데 필수적인 도구가 되고 있습니다.
기회
- AI 및 자동화의 발전
AI와 자동화의 발전은 프로세스의 정확성, 효율성, 그리고 속도를 향상시켜 유럽 증후군 다중진단 시장을 혁신하고 있습니다. AI 기반 알고리즘은 증후군 진단 플랫폼에 통합되어 복잡한 데이터 세트를 분석하고, 병원균을 더욱 정확하게 식별하며, 위양성 또는 위음성 가능성을 줄이고 있습니다. 머신러닝 모델은 결과 해석을 간소화하여 임상 의사 결정을 가속화하고, 인적 오류를 최소화합니다. 자동화는 검체 처리, 처리 및 결과 생성을 더욱 최적화하여 숙련된 인력에 대한 의존도를 줄이고 전반적인 검사실 워크플로우 효율성을 향상시킵니다. AI 기반 예측 분석은 또한 질병의 조기 감지 및 발병 모니터링을 지원하여 의료 서비스 제공자가 사전 예방 조치를 취할 수 있도록 합니다. 증후군 다중진단에 자동화를 통합하면 일관되고 처리량이 높은 검사를 보장할 수 있습니다. 이는 특히 환자 수가 많은 대규모 의료 시설과 진단 센터에 유용합니다. AI가 지속적으로 발전함에 따라 증후군 진단 정확도를 높이고 시간을 단축하는 데 있어 AI의 역할이 점점 더 중요해지고 있습니다.
예를 들어,
NCBI에서 발표한 논문에 따르면, 2024년 12월, 증후군 다중 진단의 미래 발전은 신속 다중 분자 증후군 패널(RMMSP)과 예측 인공지능을 통합하여 진단 정확도를 높이고 중증 감염 환자 관리를 최적화하는 것을 포함할 수 있습니다. AI 기반 자동화는 결과 해석을 개선하고, 인적 오류를 줄이며, 업무 흐름을 간소화할 수 있습니다. AI 자동화와 분자적 혁신은 진단을 재정의하여 효율성과 정확성을 높이는 동시에 환자 치료를 개선할 것입니다. 이러한 발전은 증후군 다중 진단의 새로운 가능성을 열어 질병 탐지 및 의료 결과의 발전을 촉진할 것입니다.
AI 기반 알고리즘은 병원균 검출을 개선하고 오류를 줄이며 임상 의사 결정을 가속화합니다. 자동화는 샘플 처리를 간소화하고 숙련된 인력에 대한 의존도를 최소화합니다. AI 기반 분석은 질병 조기 발견을 지원하여 진단 역량을 향상시킵니다. 이러한 발전은 효율성과 접근성을 향상시키고 시장 확장을 촉진하여 중요한 기회를 제공합니다.
- 유럽의 고령화 인구 증가
나이가 들면서 면역 체계가 약해져 감염에 더 취약해지면서 첨단 진단 기술에 대한 수요가 증가합니다. 이러한 솔루션은 조기 발견, 시기적절한 치료, 그리고 향상된 의료 서비스를 제공하여 진단 솔루션 시장 확대와 혁신을 촉진합니다.
예를 들어,
유럽연합 공식 웹사이트인 유로스타트(Eurostat)가 발표한 자료에 따르면, 2024년 1월 1일 기준 EU 인구는 4억 4,930만 명으로 추산되며, 이 중 21.6%가 65세 이상입니다. 또한, 중위 연령은 44.7세입니다. 이러한 고령 인구 증가는 첨단 진단 기술에 대한 수요를 증가시켜 시장 성장의 기회를 제공합니다.
남유럽 인구의 21% 이상이 이미 65세 이상이며, EU의 고령 인구는 2060년까지 거의 두 배로 증가할 것으로 예상됨에 따라 첨단 진단 기술에 대한 수요가 증가할 것으로 예상됩니다. 노화로 인해 면역 체계가 약화되어 감염에 대한 취약성이 증가함에 따라, 증후군 다중 진단은 조기 발견 및 적시 치료에 중요한 역할을 하며 시장 확대의 기회를 창출할 것입니다.
제약/도전
- 진단 제품의 높은 비용
소규모 의료 시설과 자원이 부족한 환경에서는 재정적 제약으로 인해 이러한 첨단 기술을 도입하는 데 어려움을 겪고 있습니다. 증후군 다중 진단에는 신속하고 정확한 진단 검사를 위한 완전 자동화된 무작위 접근 다중 검사가 포함되어 있지만, 이러한 모든 제품은 최종 사용자가 구매하기에는 가격이 높아 시장 성장을 저해하고 있습니다.
증후군 멀티플렉스 진단에 사용되는 기구는 유지 관리 비용이 많이 들고 시약 및 소모품과 마찬가지로 본질적으로 매우 비쌉니다. 이러한 이유로 진단 제품의 높은 비용은 유럽 증후군 멀티플렉스 진단 시장 성장을 방해하는 요인으로 작용하고 있습니다.
- 저항 메커니즘 탐지의 과제
신드롬 패널은 신속하고 포괄적인 병원균 식별을 제공하지만, 가장 적절한 항생제 치료법을 결정하는 데 필수적인 특정 항생제 내성 기전을 검출하지 못하는 경우가 많습니다. 이러한 한계는 부적절하거나 효과적이지 않은 치료의 위험을 증가시켜 항생제 내성 문제의 심화에 기여할 수 있습니다. 다제내성균으로 인한 감염은 시기적절하고 표적화된 개입을 보장하기 위해 내성 마커를 정확하게 식별해야 하지만, 일부 신드롬 검사는 이러한 정보를 제공하지 못하여 임상적 의사결정을 저해합니다. 의료 서비스 제공자는 여전히 기존의 추가적인 검사 방법에 의존해야 할 수 있으며, 이는 진단 시간과 비용을 증가시켜 신드롬 검사의 전반적인 효율성을 저하시킵니다. 규제 기관과 의료 기관들이 항생제 관리 프로그램의 중요성을 강조함에 따라, 내성 기전을 효과적으로 검출하는 향상된 신드롬 진단 솔루션의 필요성이 더욱 절실해지고 있습니다. 이 문제를 완전히 해결하지 못하면 신드롬 패널 도입이 제한되고 유럽 신드롬 다중 진단 시장의 성장이 둔화됩니다.
예를 들어,
2023년 2월, NCBI 논문에 따르면 유전자형 검사는 포린 손실이나 유출 펌프 상향 조절과 같은 비효소적 내성 기전을 검출하는 데 어려움을 겪었고, 감수성이 아닌 내성만 예측했습니다. 높은 비용과 제한된 임상적 검증은 특히 그람 음성균의 유용성에 대한 우려를 불러일으켰습니다. 이러한 한계는 시장에 심각한 난관을 초래하여 정밀 항균 요법을 유도하는 데 있어 그 효과를 제한합니다.
이 시장 보고서는 최근 동향, 무역 규제, 수출입 분석, 생산 분석, 가치 사슬 최적화, 시장 점유율, 국내 및 현지 시장 참여자의 영향, 신규 매출 창출 기회 분석, 시장 규제 변화, 전략적 시장 성장 분석, 시장 규모, 카테고리별 시장 성장, 응용 분야별 틈새 시장 및 시장 지배력, 제품 승인, 제품 출시, 지리적 확장, 시장 기술 혁신 등에 대한 세부 정보를 제공합니다. 시장에 대한 자세한 정보를 원하시면 Data Bridge Market Research에 문의하여 분석 브리핑을 요청해 주십시오. 저희 팀은 시장 성장을 위한 정보에 기반한 시장 결정을 내릴 수 있도록 도와드리겠습니다.
증후군 다중진단 시장 범위
시장은 제품 유형, 감염 유형, 질병, 최종 사용자 및 유통 채널을 기준으로 다섯 가지 주요 세그먼트로 구분됩니다. 이러한 세그먼트의 성장은 산업 내 저조한 성장 세그먼트를 분석하고, 사용자에게 핵심 시장 응용 분야를 파악하기 위한 전략적 의사 결정에 도움이 되는 귀중한 시장 개요와 시장 통찰력을 제공하는 데 도움이 될 것입니다.
제품 유형
- 액세서리 및 소모품
- 패널
- 다중 호흡기 패널
- 다중 하부 호흡기 패널
- 폐렴(PN)/폐렴 플러스(PNPLUS) 패널
- Unyvero LRT 테스트
- 다른
- 다중상부호흡기패널
- 호흡기 바이러스 패널
- 호흡기 병원체 패널(RPP)/호흡기 패널 2(RP2)
- 호흡기 패널 EZ (Clia-Waived)
- 호흡기 병원체 플렉스 검사(RP Flex)
- 다른 패널
- 멀티플렉스 GI 패널
- GI 병원체 패널(GPP)
- 장내세균 패널
- 장용 바이러스 패널
- 장내 기생충 패널
- 확장된 장내세균 패널
- 다른 패널
- 다중 혈액 배양 패널
- BCID 패널(광범위 병원체 식별)
- BCID-GP 패널(그람 양성균 패널)
- BCID-GN 패널(그람 음성균 패널)
- BCID-FP 패널(진균 병원체 검출)
- 그람 양성 혈액 배양 검사(BC-GP)
- 혈액 배양 검사(BC-GN)
- 칸디다 패널
- 박테리아 패널
- 페노테스트 BC
- 다른 패널
- 다중 하부 호흡기 패널
- 수막염/뇌염 증후군 패널
- STI 테스트 패널
- 기타 증후군 다중 진단 패널
- 다중 호흡기 패널
- 기타
- 패널
- 악기
- 소프트웨어 및 서비스
감염 유형
- 바이러스의
- 라이노바이러스
- 코로나 바이러스
- 로타바이러스
- 아데노바이러스
- 기타
- 박테리아
- 포도상구균
- 폐렴균
- 보르데텔라 페르투시스
- 기타
- 곰팡이
- 기생충
- 기타
질병
- 호흡기 감염
- 위장염
- 성병
- 수막염
- 어린 시절 감염
- 면역억제
- 열대열병
- 간염
- 눈 감염
- 기타 질병
최종 사용자
- 병원
- 유형별
- 공공의
- 사적인
- 레벨별로
- 1단계
- 2단계
- 3단계
- 유형별
- 임상 실험실
- 사적인
- 공공의
- 의사 사무실
- 제약 및 생명공학 회사
- 연구소
- 기타
유통 채널
- 직접 입찰
- 소매 판매
- 온라인
- 오프라인
- 기타
증후군성 다중진단 시장 지역 분석
위에 언급된 대로 제품 유형, 감염 유형, 질병, 최종 사용자 및 유통 채널별로 시장을 분석하고 시장 규모에 대한 통찰력과 추세를 제공합니다.
독일은 빠르고 정확한 진단 결과에 대한 수요 증가와 시장 참여자들의 전략적 이니셔티브에 힘입어 시장을 선도하고 빠르게 성장할 것으로 예상됩니다.
보고서의 국가별 섹션은 개별 시장 영향 요인과 국내 시장 규제 변화도 제시하며, 이는 현재 및 미래 시장 동향에 영향을 미칩니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 동향, 포터의 5대 경쟁 요인 분석, 사례 연구 등의 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 활용됩니다. 또한, 유럽 브랜드의 존재 및 가용성, 그리고 국내 및 국내 브랜드와의 경쟁이 심화되거나 부족하여 직면하는 과제, 국내 관세 및 무역 경로의 영향 등을 고려하여 국가별 데이터를 예측 분석합니다.
증후군 다중진단 시장 점유율
시장 경쟁 구도는 경쟁사별 세부 정보를 제공합니다. 여기에는 회사 개요, 회사 재무 상태, 매출 창출, 시장 잠재력, 연구 개발 투자, 신규 시장 진출, 유럽 시장 진출, 생산 시설 및 설비, 생산 능력, 회사의 강점과 약점, 제품 출시, 제품 종류 및 범위, 응용 분야별 우위 등이 포함됩니다. 위에 제공된 데이터는 해당 회사의 시장 집중도와 관련된 데이터입니다.
증후군성 다중 진단 시장의 선두주자는 다음과 같습니다.
- F. 호프만-라 로슈 유한회사(스위스)
- DiaSorin SpA(이탈리아)
- 비오메리유(프랑스)
- Thermo Fisher Scientific Inc.(미국)
- QIAGEN(네덜란드)
- BD Veritor(BD)(미국)
- Bio-Rad Laboratories, Inc. (미국)
- 다나허 코퍼레이션(미국)
- Seegene Inc. (한국)
- Hologic, Inc. (미국)
- Bosch Healthcare Solutions GmbH(독일)
- 애벗(미국)
- QuidelOrtho Corporation(미국)
- Biocartis(벨기에)
- PathoFinder(네덜란드)
증후군 멀티플렉스 진단 시장의 최신 동향
- 2024년 11월, 로슈는 포세이다 테라퓨틱스를 약 10억 달러에 인수하는 계약을 체결했습니다. 이번 인수는 로슈의 동종이계 세포 치료, 특히 종양학, 면역학, 신경학 분야의 역량을 강화합니다. 기성품 CAR-T 치료제 개발을 가속화하여 치료 접근성을 높이고 임상 결과를 개선함으로써 환자에게 혜택을 제공하는 것을 목표로 합니다. 이 거래는 2025년 1분기에 완료될 것으로 예상됩니다.
- 2024년 9월, 로슈는 혁신적인 TAGS 기술을 사용하여 12종의 호흡기 바이러스를 고처리량으로 동시에 검출하는 최초의 테스트를 시작했습니다. 새로운 TAGS(온도 활성화 신호 생성) 기술을 통해 고처리량 분자 진단 분석기인 Cobas 5800, 6800, 8800에서 단일 환자 검체에서 최대 15개의 표적을 동시에 검출할 수 있었습니다.
- 2023년 3월, 로슈는 미국 FDA 종양학 자문위원회가 이전에 치료받지 않은 미만성 거대 B세포 림프종(DLBCL) 환자를 대상으로 폴리비와 R-CHP 병용 요법을 승인했다고 발표했습니다. 이 병용 요법은 표준 R-CHOP 요법 대비 무진행 생존기간(PFS)을 유의미하게 개선하여 DLBCL 환자에게 유망한 1차 치료 옵션을 제공했습니다. 이번 결정은 지난 20년간 치료에서 제한적인 진전을 보여온 이 공격적인 암 환자의 치료 결과를 개선할 것으로 예상됩니다.
- 2022년 3월, MDiaSorin의 Luminex는 대변 샘플에서 16가지 세균, 바이러스, 기생충 병원균을 검출하는 복합 검사인 xMAP NxTAG 위장관 병원균 패널(GPP)에 대한 CE 마크를 획득했습니다. MAGPIX 시스템용으로 설계된 이 제품은 당일 결과를 제공하여 유럽 전역의 임상 검사실에서 신속한 진단, 항생제 관리 및 고처리량 검사를 향상시킵니다.
- 2023년 5월, DiaSorin SpA는 이탈리아에서 MeMed BV 검사의 유통 계약을 체결하며 MeMed와의 파트너십을 강화했습니다. AI가 통합된 이 검사는 박테리아 감염과 바이러스 감염을 구별하여 항생제 결정에 도움을 줍니다. 전 세계적으로 검증된 이 검사는 환자 관리를 개선하고 항생제 내성 퇴치를 위한 노력을 지원합니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTAL ANALYSIS
4.2 PORTERS FIVE FORCES ANALYSIS
4.3 INDUSTRY INSIGHTS
4.4 TECHNOLOGY ROADMAP
5 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING PREVALENCE OF INFECTIOUS DISEASES
6.1.2 RISING ADOPTION OF MOLECULAR DIAGNOSTICS TECHNIQUES
6.1.3 STRATEGIC INITIATIVES TAKEN BY MARKET PLAYERS
6.1.4 INCREASING DEMAND FOR FAST AND ACCURATE DIAGNOSTIC RESULTS
6.2 RESTRAINTS
6.2.1 HIGH COST OF DIAGNOSTIC PRODUCTS
6.2.2 VARIABILITY IN TEST PERFORMANCE ACROSS DIFFERENT MANUFACTURERS
6.3 OPPORTUNITIES
6.3.1 ADVANCEMENTS IN AI & AUTOMATION
6.3.2 RISING AGING POPULATION IN EUROPE
6.3.3 RISING HOSPITAL-ACQUIRED INFECTIONS
6.4 CHALLENGES
6.4.1 CHALLENGES IN DETECTING RESISTANCE MECHANISMS
6.4.2 LACK OF MEDICAL PROFESSIONALS IN EUROPE
7 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 ACCESSORIES & CONSUMABLES
7.2.1 PANELS
7.2.1.1 MULTIPLEX RESPIRATORY PANELS
7.2.1.1.1 MULTIPLEX LOWER RESPIRATORY PANELS
7.2.1.1.2 PNEUMONIA (PN)/PNEUMONIA PLUS (PNPLUS) PANELS
7.2.1.1.3 UNYVERO LRT TEST
7.2.1.1.4 OTHER
7.2.1.2 MULTIPLEX UPPER RESPIRATORY PANELS
7.2.1.2.1 RESPIRATORY VIRAL PANEL
7.2.1.2.2 RESPIRATORY PATHOGEN PANEL (RPP)/RESPIRATORY PANEL 2 (RP2)
7.2.1.2.3 RESPIRATORY PANEL EZ (CLIA-WAIVED)
7.2.1.2.4 RESPIRATORY PATHOGENS FLEX TEST (RP FLEX)
7.2.1.2.5 OTHER PANELS
7.2.1.3 MULTIPLEX GI PANELS
7.2.1.3.1 GI PATHOGEN PANEL (GPP)
7.2.1.3.2 ENTERIC BACTERIAL PANEL
7.2.1.3.3 ENTERIC VIRAL PANEL
7.2.1.3.4 ENTERIC PARASITE PANEL
7.2.1.3.5 EXTENDED ENTERIC BACTERIAL PANEL
7.2.1.3.6 OTHER PANELS
7.2.1.4 MULTIPLEX BLOOD CULTURE PANELS
7.2.1.4.1 BCID PANEL (BROAD-SPECTRUM PATHOGEN IDENTIFICATION)
7.2.1.4.2 BCID-GP PANEL (GRAM-POSITIVE BACTERIA PANEL)
7.2.1.4.3 BCID-GN PANEL (GRAM-NEGATIVE BACTERIA PANEL)
7.2.1.4.4 BCID-FP PANEL (FUNGAL PATHOGEN DETECTION)
7.2.1.4.5 GRAM-POSITIVE BLOOD CULTURE TEST (BC-GP)
7.2.1.4.6 BLOOD CULTURE TEST (BC-GN)
7.2.1.4.7 CANDIDA PANEL
7.2.1.4.8 BACTERIA PANEL
7.2.1.4.9 PHENOTEST BC
7.2.1.4.10 OTHER PANELS
7.2.1.5 MENINGITIS/ENCEPHALITIS SYNDROMIC PANEL
7.2.1.6 STI TEST PANELS
7.2.1.7 OTHER SYNDROMIC MULTIPLEX DIAGNOSTIC PANELS
7.3 INSTRUMENTS
7.4 SOFTWARE & SERVICES
8 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE
8.1 OVERVIEW
8.2 VIRAL
8.2.1 RHINOVIRUS
8.2.2 CORONAVIRUS
8.2.3 ROTAVIRUS
8.2.4 ADENOVIRUS
8.2.5 OTHERS
8.3 BACTERIAL
8.3.1 STAPHYLOCOCCUS
8.3.2 PNEUMONIA
8.3.3 BORDETELLA PERTUSSIS
8.3.4 OTHERS
8.4 FUNGAL
8.5 PARASITES
8.6 OTHERS
9 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE
9.1 OVERVIEW
9.2 RESPIRATORY INFECTIONS
9.3 GASTROENTERITIS
9.4 SEXUALLY TRANSMITTED INFECTIONS
9.5 MENINGITIS
9.6 CHILDHOOD INFECTIONS
9.7 IMMUNOSUPPRESSION
9.8 TROPICAL FEVER
9.9 HEPATITIS
9.1 EYE INFECTIONS
9.11 OTHER DISEASES
10 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.2.1 BY TYPE,
10.2.1.1 PRIVATE
10.2.1.2 PUBLIC
10.2.2 BY LEVEL
10.2.2.1 TIER 1
10.2.2.2 TIER 2
10.2.2.3 TIER 3
10.3 CLINICAL LABORATORIES
10.3.1 BY TYPE
10.3.1.1 PRIVATE
10.3.1.2 PUBLIC
10.4 PHYSICIAN OFFICES
10.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.6 RESEARCH INSTITUTES
10.7 OTHERS
11 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 RETAIL SALES
11.3.1 ONLINE
11.3.2 OFFLINE
11.4 OTHERS
12 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY COUNTRIES
12.1 EUROPE
12.1.1 GERMANY
12.1.2 U.K.
12.1.3 FRANCE
12.1.4 ITALY
12.1.5 SPAIN
12.1.6 RUSSIA
12.1.7 NETHERLANDS
12.1.8 TURKEY
12.1.9 BELGIUM
12.1.10 SWEDEN
12.1.11 POLAND
12.1.12 DENMARK
12.1.13 NORWAY
12.1.14 FINLAND
12.1.15 REST OF EUROPE
13 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: EUROPE
14 SWOT ANALYSIS
15 COMPANY PROFILES
15.1 F. HOFFMANN-LA ROCHE LTD
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 PRODUCT PORTFOLIO
15.1.4 RECENT DEVELOPMENTS
15.2 DIASORIN S.P.A
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 SOULUTION PORTFOLIO
15.2.4 RECENT DEVELOPMENT
15.3 BIOMERIEUX
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 PRODUCT PORTFOLIO
15.3.4 RECENT DEVELOPMENTS/NEWS
15.4 THERMO FISHER SCIENTIFIC INC.
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 PRODUCT PORTFOLIO
15.4.4 RECENT DEVELOPMENTS
15.5 QIAGEN
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 PRODUCT PORTFOLIO
15.5.4 RECENT DEVELOPMENTS
15.6 ABBOTT
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENTS/NEWS
15.7 BD VERITOR (BD)
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT DEVELOPMENTS
15.8 BIOCARTIS
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENT
15.9 BIO-RAD LABORATORIES, INC.
15.9.1 COMPANY SNAPSHOT
15.9.2 REVENUE ANALYSIS
15.9.3 PRODUCT PORTFOLIO
15.9.4 RECENT DEVELOPMENT
15.1 BOSCH HEALTHCARE SOLUTIONS GMBH
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENT
15.11 DANAHER CORPORATION
15.11.1 COMPANY SNAPSHOT
15.11.2 REVENUE ANALYSIS
15.11.3 PRODUCT PORTFOLIO
15.11.4 RECENT DEVELOPMENT
15.12 HOLOGIC, INC.
15.12.1 COMPANY SNAPSHOT
15.12.2 REVENUE ANALYSIS
15.12.3 PRODUCT PORTFOLIO
15.12.4 RECENT DEVELOPMENTS/NEWS
15.13 PATHOFINDER
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENT
15.14 QUIDELORTHO CORPORATION
15.14.1 COMPANY SNAPSHOT
15.14.2 REVENUE ANALYSIS
15.14.3 PRODUCT PORTFOLIO
15.14.4 RECENT DEVELOPMENTS/NEWS
15.15 SEEGENE INC.
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENTS
16 QUESTIONNAIRE
17 RELATED REPORTS
표 목록
TABLE 1 COST OF MULTIPLEX DIAGNOSTIC PRODUCT IN USD
TABLE 2 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 3 EUROPE ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 4 EUROPE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 5 EUROPE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 6 EUROPE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 7 EUROPE MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 8 EUROPE MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 9 EUROPE MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 10 EUROPE MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 11 EUROPE MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 12 EUROPE MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 13 EUROPE MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 14 EUROPE MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 15 EUROPE MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 16 EUROPE MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 17 EUROPE MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 18 EUROPE MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 19 EUROPE MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 20 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 21 EUROPE VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 22 EUROPE BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 23 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 24 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 25 EUROPE HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 26 EUROPE HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 27 EUROPE CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 28 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 29 EUROPE RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 30 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)
TABLE 31 GERMANY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 32 GERMANY ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 33 GERMANY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 34 GERMANY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 35 GERMANY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 36 GERMANY MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 37 GERMANY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 38 GERMANY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 39 GERMANY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 40 GERMANY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 41 GERMANY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 42 GERMANY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 43 GERMANY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 44 GERMANY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 45 GERMANY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 46 GERMANY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 47 GERMANY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 48 GERMANY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 49 GERMANY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 50 GERMANY VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 51 GERMANY BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 52 GERMANY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 53 GERMANY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 54 GERMANY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 55 GERMANY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 56 GERMANY CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 57 GERMANY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 58 GERMANY RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 59 U.K. SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 60 U.K. ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 61 U.K. PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 62 U.K. PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 63 U.K. PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 64 U.K. MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 65 U.K. MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 66 U.K. MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 67 U.K. MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 68 U.K. MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 69 U.K. MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 70 U.K. MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 71 U.K. MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 72 U.K. MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 73 U.K. MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 74 U.K. MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 75 U.K. MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 76 U.K. MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 77 U.K. SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 78 U.K. VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 79 U.K. BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 80 U.K. SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 81 U.K. SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 82 U.K. HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 83 U.K. HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 84 U.K. CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 85 U.K. SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 86 U.K. RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 87 FRANCE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 88 FRANCE ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 89 FRANCE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 90 FRANCE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 91 FRANCE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 92 FRANCE MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 93 FRANCE MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 94 FRANCE MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 95 FRANCE MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 96 FRANCE MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 97 FRANCE MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 98 FRANCE MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 99 FRANCE MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 100 FRANCE MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 101 FRANCE MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 102 FRANCE MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 103 FRANCE MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 104 FRANCE MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 105 FRANCE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 106 FRANCE VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 107 FRANCE BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 108 FRANCE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 109 FRANCE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 110 FRANCE HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 111 FRANCE HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 112 FRANCE CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 113 FRANCE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 114 FRANCE RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 115 ITALY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 116 ITALY ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 117 ITALY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 118 ITALY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 119 ITALY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 120 ITALY MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 121 ITALY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 122 ITALY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 123 ITALY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 124 ITALY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 125 ITALY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 126 ITALY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 127 ITALY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 128 ITALY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 129 ITALY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 130 ITALY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 131 ITALY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 132 ITALY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 133 ITALY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 134 ITALY VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 135 ITALY BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 136 ITALY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 137 ITALY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 138 ITALY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 139 ITALY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 140 ITALY CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 141 ITALY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 142 ITALY RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 143 SPAIN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 144 SPAIN ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 145 SPAIN PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 146 SPAIN PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 147 SPAIN PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 148 SPAIN MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 149 SPAIN MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 150 SPAIN MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 151 SPAIN MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 152 SPAIN MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 153 SPAIN MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 154 SPAIN MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 155 SPAIN MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 156 SPAIN MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 157 SPAIN MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 158 SPAIN MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 159 SPAIN MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 160 SPAIN MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 161 SPAIN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 162 SPAIN VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 163 SPAIN BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 164 SPAIN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 165 SPAIN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 166 SPAIN HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 167 SPAIN HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 168 SPAIN CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 169 SPAIN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 170 SPAIN RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 171 RUSSIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 172 RUSSIA ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 173 RUSSIA PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 174 RUSSIA PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 175 RUSSIA PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 176 RUSSIA MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 177 RUSSIA MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 178 RUSSIA MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 179 RUSSIA MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 180 RUSSIA MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 181 RUSSIA MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 182 RUSSIA MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 183 RUSSIA MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 184 RUSSIA MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 185 RUSSIA MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 186 RUSSIA MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 187 RUSSIA MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 188 RUSSIA MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 189 RUSSIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 190 RUSSIA VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 191 RUSSIA BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 192 RUSSIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 193 RUSSIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 194 RUSSIA HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 195 RUSSIA HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 196 RUSSIA CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 197 RUSSIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 198 RUSSIA RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 199 NETHERLANDS SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 200 NETHERLANDS ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 201 NETHERLANDS PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 202 NETHERLANDS PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 203 NETHERLANDS MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 204 NETHERLANDS MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 205 NETHERLANDS MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 206 NETHERLANDS MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 207 NETHERLANDS MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 208 NETHERLANDS MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 209 NETHERLANDS MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 210 NETHERLANDS MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 211 NETHERLANDS MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 212 NETHERLANDS MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 213 NETHERLANDS MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 214 NETHERLANDS MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 215 NETHERLANDS SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 216 NETHERLANDS VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 217 NETHERLANDS BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 218 NETHERLANDS SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 219 NETHERLANDS SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 220 NETHERLANDS HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 221 NETHERLANDS HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 222 NETHERLANDS CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 223 NETHERLANDS SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 224 NETHERLANDS RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 225 SWITZERLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 226 SWITZERLAND ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 227 SWITZERLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 228 SWITZERLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 229 SWITZERLAND MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 230 SWITZERLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 231 SWITZERLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 232 SWITZERLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 233 SWITZERLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 234 SWITZERLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 235 SWITZERLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 236 SWITZERLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 237 SWITZERLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 238 SWITZERLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 239 SWITZERLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 240 SWITZERLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 241 SWITZERLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 242 SWITZERLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 243 SWITZERLAND VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 244 SWITZERLAND BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 245 SWITZERLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 246 SWITZERLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 247 SWITZERLAND HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 248 SWITZERLAND HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 249 SWITZERLAND CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 250 SWITZERLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 251 SWITZERLAND RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 252 TURKEY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 253 TURKEY ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 254 TURKEY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 255 TURKEY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 256 TURKEY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 257 TURKEY MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 258 TURKEY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 259 TURKEY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 260 TURKEY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 261 TURKEY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 262 TURKEY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 263 TURKEY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 264 TURKEY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 265 TURKEY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 266 TURKEY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 267 TURKEY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 268 TURKEY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 269 TURKEY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 270 TURKEY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 271 TURKEY VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 272 TURKEY BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 273 TURKEY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 274 TURKEY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 275 TURKEY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 276 TURKEY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 277 TURKEY CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 278 TURKEY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 279 TURKEY RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 280 BELGIUM SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 281 BELGIUM ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 282 BELGIUM PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 283 BELGIUM PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 284 BELGIUM PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 285 BELGIUM MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 286 BELGIUM MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 287 BELGIUM MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 288 BELGIUM MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 289 BELGIUM MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 290 BELGIUM MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 291 BELGIUM MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 292 BELGIUM MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 293 BELGIUM MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 294 BELGIUM MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 295 BELGIUM MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 296 BELGIUM MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 297 BELGIUM MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 298 BELGIUM SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 299 BELGIUM VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 300 BELGIUM BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 301 BELGIUM SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 302 BELGIUM SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 303 BELGIUM HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 304 BELGIUM HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 305 BELGIUM CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 306 BELGIUM SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 307 BELGIUM RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 308 SWEDEN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 309 SWEDEN ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 310 SWEDEN PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 311 SWEDEN PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 312 SWEDEN PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 313 SWEDEN MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 314 SWEDEN MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 315 SWEDEN MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 316 SWEDEN MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 317 SWEDEN MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 318 SWEDEN MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 319 SWEDEN MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 320 SWEDEN MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 321 SWEDEN MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 322 SWEDEN MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 323 SWEDEN MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 324 SWEDEN MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 325 SWEDEN MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 326 SWEDEN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 327 SWEDEN VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 328 SWEDEN BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 329 SWEDEN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 330 SWEDEN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 331 SWEDEN HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 332 SWEDEN HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 333 SWEDEN CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 334 SWEDEN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 335 SWEDEN RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 336 POLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 337 POLAND ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 338 POLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 339 POLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 340 POLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 341 POLAND MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 342 POLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 343 POLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 344 POLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 345 POLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 346 POLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 347 POLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 348 POLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 349 POLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 350 POLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 351 POLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 352 POLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 353 POLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 354 POLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 355 POLAND VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 356 POLAND BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 357 POLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 358 POLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 359 POLAND HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 360 POLAND HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 361 POLAND CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 362 POLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 363 POLAND RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 364 DENMARK SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 365 DENMARK ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 366 DENMARK PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 367 DENMARK PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 368 DENMARK PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 369 DENMARK MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 370 DENMARK MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 371 DENMARK MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 372 DENMARK MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 373 DENMARK MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 374 DENMARK MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 375 DENMARK MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 376 DENMARK MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 377 DENMARK MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 378 DENMARK MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 379 DENMARK MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 380 DENMARK MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 381 DENMARK MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 382 DENMARK SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 383 DENMARK VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 384 DENMARK BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 385 DENMARK SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 386 DENMARK SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 387 DENMARK HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 388 DENMARK HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 389 DENMARK CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 390 DENMARK SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 391 DENMARK RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 392 NORWAY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 393 NORWAY ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 394 NORWAY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 395 NORWAY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 396 NORWAY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 397 NORWAY MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 398 NORWAY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 399 NORWAY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 400 NORWAY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 401 NORWAY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 402 NORWAY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 403 NORWAY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 404 NORWAY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 405 NORWAY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 406 NORWAY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 407 NORWAY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 408 NORWAY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 409 NORWAY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 410 NORWAY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 411 NORWAY VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 412 NORWAY BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 413 NORWAY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 414 NORWAY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 415 NORWAY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 416 NORWAY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 417 NORWAY CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 418 NORWAY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 419 NORWAY RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 420 FINLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 421 FINLAND ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 422 FINLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 423 FINLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 424 FINLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 425 FINLAND MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 426 FINLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 427 FINLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 428 FINLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 429 FINLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 430 FINLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 431 FINLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 432 FINLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 433 FINLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 434 FINLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 435 FINLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 436 FINLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 437 FINLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 438 FINLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 439 FINLAND VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 440 FINLAND BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 441 FINLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 442 FINLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 443 FINLAND HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 444 FINLAND HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 445 FINLAND CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 446 FINLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 447 FINLAND RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 448 REST OF EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
그림 목록
FIGURE 1 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: SEGMENTATION
FIGURE 2 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: DROC ANALYSIS
FIGURE 4 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: COUNTRY-WISE MARKET ANALYSIS
FIGURE 5 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: INTERVIEW DEMOGRAPHICS.
FIGURE 7 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: SEGMENTATION
FIGURE 11 THREE SEGMENTS COMPRISE THE EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE (2024)
FIGURE 12 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: EXECUTIVE SUMMARY
FIGURE 13 STRATEGIC DECISIONS
FIGURE 14 RISING PREVALENCE OF INFECTIOUS DISEASES IS EXPECTED TO DRIVE THE EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET GROWTH IN THE FORECAST PERIOD OF 2025 TO 2032
FIGURE 15 ACCESSORIES & CONSUMABLES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET IN THE FORECAST PERIOD OF 2025 & 2032
FIGURE 16 DROC ANALYSIS
FIGURE 17 TOTAL NUMBER OF CASES OF TUBERCULOSIS IN 2022 AND 2023
FIGURE 18 TOTAL NUMBER OF CASES OF SEXUALLY TRANSMITTED INFECTIONS (STIS)
FIGURE 19 INCREASE IN THE SHARE OF THE POPULATION AGED 65 YEARS AND OVER BETWEEN 2014 AND 2024
FIGURE 20 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCT TYPE, 2024
FIGURE 21 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCT TYPE, 2025 TO 2032 (USD THOUSAND)
FIGURE 22 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCT TYPE, CAGR (2025-2032)
FIGURE 23 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 24 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY INFECTION TYPE, 2024
FIGURE 25 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY INFECTION TYPE, 2025 TO 2032 (USD THOUSAND)
FIGURE 26 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY INFECTION TYPE, CAGR (2025-2032)
FIGURE 27 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY INFECTION TYPE, LIFELINE CURVE
FIGURE 28 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISEASE, 2024
FIGURE 29 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISEASE, 2025 TO 2032 (USD THOUSAND)
FIGURE 30 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISEASE, CAGR (2025-2032)
FIGURE 31 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISEASE, LIFELINE CURVE
FIGURE 32 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY END USER, 2024
FIGURE 33 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY END USER, 2025 TO 2032 (USD THOUSAND)
FIGURE 34 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY END USER, CAGR (2025-2032)
FIGURE 35 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY END USER, LIFELINE CURVE
FIGURE 36 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISTRIBUTION CHANNEL, 2024
FIGURE 37 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISTRIBUTION CHANNEL, 2025 TO 2032 (USD THOUSAND)
FIGURE 38 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISTRIBUTION CHANNEL, CAGR (2025-2032)
FIGURE 39 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 40 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: SNAPSHOT, 2024
FIGURE 41 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: COMPANY SHARE 2024 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
